Breaking News - The Fly

Open Search

INDP

Indaptus Therapeutics

$

()

Indaptus Therapeutics announces interim data from Phase 1 INDP-D101 trial

INDP

11/6/2023 - 08:13am

Indaptus to present interim data of first cohort in trial of INDP-D101

INDP

10/31/2023 - 09:12am

Indaptus Therapeutics doses first patient in second cohort of study of Decoy20

INDP

9/19/2023 - 08:03am

Indaptus Therapeutics reports Q2 EPS (39c) vs (46c) last year

INDP

8/14/2023 - 08:02am

Indaptus Therapeutics announces opening of next cohort in trial of Decoy20

INDP

8/10/2023 - 08:46am

Indaptus Therapeutics appoints Waltzman as Chief Medical Officer

INDP , MTEM

8/7/2023 - 08:09am

Indaptus Therapeutics expects cash to fund operations into 2Q24

INDP

5/11/2023 - 07:06am

Indaptus Therapeutics reports Q1 EPS (51c) vs. (41c) last year

INDP

5/11/2023 - 07:05am

Indaptus receives notice of allowance from IP India for Decoy platform

INDP

5/9/2023 - 08:25am

Indaptus Therapeutics presents data on preclinical efficacy of Decoy

INDP

4/19/2023 - 08:10am

Indaptus Therapeutics receives Brazilian patent allowance for Decoy platform

INDP

4/17/2023 - 08:15am

Indaptus Therapeutics price target lowered to $12 from $15 at H.C. Wainwright

INDP

3/20/2023 - 06:16am

Indaptus Therapeutics reports 2022 EPS ($1.73) vs ($1.89) last year

INDP

3/17/2023 - 08:07am

Indaptus Therapeutics activates Emory Winship Cancer Institute as trial site

INDP

3/13/2023 - 08:41am

Indaptus Therapeutics doses first subject in ongoing Phase 1 lab

INDP

3/7/2023 - 08:27am